News Search Results
Jul 08, 2025, 09:00 ET Metabolon Announces a Quarter Century of Scientific Innovation, Industry Leadership, and Transformative Contributions to Life Science
measures. Trusted by Leading Organizations: Metabolon serves thousands of clients worldwide, including the majority of the top pharmaceutical, biotechnology, and academic institutions. Metabolon empowers these organizations to shorten development timelines, accelerate pipeline progression, and support
More news about: Metabolon, Inc.
Jul 08, 2025, 09:00 ET Metabolon Announces a Quarter Century of Scientific Innovation, Industry Leadership, and Transformative Contributions to Life Science
measures. Trusted by Leading Organizations: Metabolon serves thousands of clients worldwide, including the majority of the top pharmaceutical, biotechnology, and academic institutions. Metabolon empowers these organizations to shorten development timelines, accelerate pipeline progression, and support
More news about: Metabolon, Inc.
Jul 08, 2025, 08:30 ET Oncolytics Biotech® Highlights Transformative Pelareorep Survival Data in Multiple Tumors and Commitment to Registration-Enabling Studies
website, that provides detailed clinical and translational data. About Oncolytics Biotech Inc. Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized
More news about: Oncolytics Biotech® Inc.
Jul 08, 2025, 08:00 ET ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review
as its new Vice President, Labeling & Strategy. In this role, he will lead compliance and regulatory advisory services for pharmaceutical, biotechnology, medical device, and diagnostic companies.
More news about: ProPharma Group Holdings LLC
Jul 08, 2025, 08:00 ET Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America
solutions in healthcare using artificial intelligence and biotechnologies. With a focus on pushing the boundaries of what is possible in AI and biotechnology, Avant serves a diverse range of industries, driving progress and efficiency through state-of-the-art technology. More information about
More news about: Avant Technologies Inc.
Jul 08, 2025, 07:30 ET Soligenix Corporate Update Letter - Key Highlights and Upcoming Milestones
procurement contracts with the U.S. Government or other countries, that it will be able to compete with larger and better financed competitors in the biotechnology industry, that changes in health care practice, third party reimbursement limitations and Federal and/or state health care reform initiatives will
More news about: SOLIGENIX, INC.
Jul 08, 2025, 02:00 ET Independent Meta-Analysis Shows SkylineDx's Merlin CP-GEP Assay Accurately Stratifies Patients for Sentinel Lymph Node Biopsy Selection
www.merlinmelanomatest.com About SkylineDx SkylineDx is a biotechnology company focused on research and development of molecular diagnostics in oncology, inflammatory and infectious diseases. SkylineDx uses its expertise
More news about: SkylineDx
Jul 07, 2025, 22:08 ET Celltrion USA announces U.S. launch of denosumab biosimilars, STOBOCLO® and OSENVELT® (denosumab-bmwo)
biologic ZYMFENTRA® (infliximab-dyyb). Celltrion USA will continue to leverage Celltrion's unique heritage in biotechnology, supply chain excellence and best-in-class sales capabilities to improve access to high-quality biopharmaceuticals for U.S. patients. For more information,
More news about: Celltrion
Jul 07, 2025, 22:00 ET SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V
July 7, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China
More news about: SCG Cell Therapy Pte Ltd
Jul 07, 2025, 16:30 ET BIOVAXYS ENGAGES ENCLAVE CAPITAL LLC TO ACT AS AN AGENT IN BROKERED PRIVATE PLACEMENT OFFERING
receive the required regulatory approvals. With regards to BioVaxys' business, there are a number of risks that could affect the development of its biotechnology products, including, without limitation, the need for additional capital to fund clinical trials, its lack of operating history, uncertainty about
More news about: BioVaxys Technology Corp.
Jul 07, 2025, 16:05 ET INOVIO to Present at Upcoming Scientific Conference
MEETING, Pa., July 7, 2025 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious
More news about: INOVIO Pharmaceuticals, Inc.
Jul 07, 2025, 14:54 ET Global Industrial Enzyme Markets: Innovation, Impact, and Growth
"The global industrial enzyme market is experiencing rapid growth, driven by advances in biotechnology and increasing demand across sectors like food, biofuels, and textiles. These powerful biocatalysts are revolutionizing industrial processes with greater efficiency and sustainability."
More news about: BCC Research LLC
Jul 07, 2025, 14:00 ET Myosin Therapeutics Publishes Two Foundational Studies in the Journal Cell Highlighting a Novel Approach to Treating Cancer and Brain Disorders
Myosin Therapeutics, a clinical-stage biotechnology company advancing first-in-class therapies targeting molecular motor proteins, announced the publication of two major papers in the journal Cell
More news about: Myosin Therapeutics Inc.
Jul 07, 2025, 13:58 ET Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers - FTRE
global contract research organization ("CRO") that provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers. The Company claims to have the "scale and expertise to advise, design and deliver [its] customers' programs, projects
More news about: Pomerantz LLP
Jul 07, 2025, 13:58 ET Pomerantz Law Firm Announces the Filing of a Class Action Against PepGen Inc. and Certain Officers - PEPG
[Click here for information about joining the class action] PepGen is a clinical-stage biotechnology company that focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases.
More news about: Pomerantz LLP
Jul 07, 2025, 13:58 ET Pomerantz Law Firm Announces the Filing of a Class Action Against 3D Systems Corporation and Certain Officers - DDD
Medicine Program focuses on "the use of additive manufacturing for human organ transplantation." Since 2018, 3D Systems has partnered with the biotechnology company United Therapeutics Corporation ("United") "with a long-term goal of developing the capability to 3D print lungs that will allow patients
More news about: Pomerantz LLP
Jul 07, 2025, 11:59 ET 26th Edition Global Family Office Investment Summit Held in Cannes Under the Patronage of Cannes Mayor H.E. David Lisnard
Artificial Intelligence & Web3 InnovationSustainable Infrastructure & Renewable EnergyHealthcare, Biotechnology & LongevityPhilanthropy, Family Legacy & GovernanceReal Estate, Private Equity & Global MarketsCross-border
More news about: Ritossa Family Office
Jul 07, 2025, 11:50 ET Cervical Cancer Treatment Market Size is Expected to Reach USD 14.91 Billion by 2030, with CAGR of 5.7%, Rising Prevalence of Cervical Cancer Fuels | The Insight Partners
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 07, 2025, 11:30 ET mRNA Sequencing Market Size to Hit USD 4.02 billion by 2031, Growing at 13.6% CAGR, Benefits from Surging Prevalence of Cancer | The Insight Partners
end user, the mRNA sequencing market is segmented into healthcare facilities, pharmaceutical and biotechnology companies, clinical research organizations, and others. The pharmaceutical and biotechnology companies segment held the largest share of the market in 2024.The mRNA sequencing market
More news about: The Insight Partners
Jul 07, 2025, 11:15 ET Procedure Trays Market Size Projected to Exceed USD 49.32 Billion by 2031 at a 10.2% CAGR, Driven by Increasing Surgical Procedures and Emphasis on Infection Control | The Insight Partners'
consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact
More news about: The Insight Partners
Jul 07, 2025, 10:31 ET World-Class, Turnkey Cro Facility Available Through Bankruptcy Sale with Full Suite of Lab Equipment & Intellectual Property
features sophisticated infrastructure and enhanced security for sensitive operations. Engineered to support the development of pharmaceuticals, biotechnology products and medical devices, the facility's integrated laboratories are designed to deliver toxicology, safety pharmacology and bioanalytic characterization
More news about: Hilco Global
Jul 07, 2025, 10:15 ET Biochip Market to Reach USD 17.99 Billion by 2030 -- Driven by Diagnostics, Personalized Medicine, and Drug Discovery | Valuates Reports
July 7, 2025 /PRNewswire/ -- Biochip Market is Segmented by Type (Microarrays, Microfluidics), by Application (Biotechnology and Pharmaceutical Companies, Hospitals and Diagnostics Centers, Academic & Research Institutes).
More news about: Valuates Reports
Jul 07, 2025, 10:01 ET Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
patients benefit from safer, more effective therapies. Understanding the Platform Calidi Biotherapeutics is clinical stage biotechnology company that is developing genetic medicines and proprietary genetically engineered oncolytic viruses. Calidi's RedTail systemic antitumor virotherapy
More news about: NetworkNewsWire
Jul 07, 2025, 08:30 ET Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs
patients benefit from safer, more effective therapies. Understanding the Platform Calidi Biotherapeutics is clinical stage biotechnology company that is developing genetic medicines and proprietary genetically engineered oncolytic viruses. Calidi's RedTail systemic antitumor virotherapy
More news about: NetworkNewsWire
Jul 07, 2025, 08:05 ET Rigel Pharmaceuticals, Inc. Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
employees vesting over four years with a one-year cliff. About RigelRigel Pharmaceuticals, Inc. (Nasdaq: RIGL) is a biotechnology company dedicated to discovering, developing and providing novel therapies that significantly improve the lives of patients with hematologic disorders
More news about: Rigel Pharmaceuticals, Inc.